OKYO Pharma to Showcase Urcosimod Data and Convene Key Advisory Board at 2026 ASCRS Meeting
TipRanks (Tue, 7-Apr 7:33 AM ET)
Globe Newswire (Tue, 7-Apr 7:00 AM ET)
OKYO Pharma Announces Chairman and Founder Acquires Shares
Globe Newswire (Thu, 19-Mar 12:00 PM ET)
OKYO Pharma Announces Director Acquires Shares
Globe Newswire (Thu, 19-Mar 10:00 AM ET)
OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
Globe Newswire (Thu, 19-Mar 7:00 AM ET)
Globe Newswire (Wed, 18-Mar 7:00 AM ET)
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Globe Newswire (Mon, 23-Feb 11:00 AM ET)
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
Globe Newswire (Thu, 12-Feb 10:20 PM ET)
OKYO Pharma Announces Public Offering of Ordinary Shares
Globe Newswire (Thu, 12-Feb 4:01 PM ET)
OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners
Globe Newswire (Wed, 11-Feb 10:09 AM ET)
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Okyo Pharma Limited - trades on the NASDAQ stock market under the symbol OKYO.
As of April 10, 2026, OKYO stock price declined to $1.51 with 169,010 million shares trading.
OKYO has a beta of 0.69, meaning it tends to be less sensitive to market movements. OKYO has a correlation of 0.01 to the broad based SPY ETF.
OKYO has a market cap of $79.24 million. This is considered a Micro Cap stock.
In the last 3 years, OKYO traded as high as $3.35 and as low as $.81.
OKYO has outperformed the market in the last year with a return of +41.1%, while the SPY ETF gained +30.9%. However, in the most recent history, OKYO shares have underperformed the stock market with its stock returning -45.3% in the last 3 month period and -1.3% for the last 2 week period, while SPY has returned -1.8% and +7.2%, respectively.
OKYO support price is $1.48 and resistance is $1.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OKYO shares will trade within this expected range on the day.